Tue, Aug 10, 2021
The Covaxin vaccine received DCGI approval for Phase I and II Human Clinical Trials in July 2020.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.